The therapies are poised to revolutionize the cancer care landscape, but it will require collaboration across the industry, ...

Siemens Healthineers’ David Pacitti said the company wants to support health systems through long-term partnerships.

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

More about Radiopharm Theranostics Limited Radiopharm Theranostics Limited operates in the medical technology industry, focusing on the development of radiopharmaceutical products for diagnostic ...

Theranostics combines the use of diagnostic ... are also working with GE HealthCare to expand the potential of PET/CT technology, which is crucial for diagnosis of the disease, staging ...

Cancer metabolism has been an active area of interest in the field for this decade and considered a promising therapeutic ...

Here, Professor Marie-Laure Yaspo, Chief Scientific Officer at Alacris Theranostics, discusses her work on molecular tumour profiling, and how MGI’s technology has assisted in acceleration of ...

Radiopharm Theranostics (ASX:RAD; NASDAQ:RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceut ...

Established in 2022, the Lancet Oncology Commission on Radiotherapy and Theranostics was led by the IAEA and includes experts from 44 academic institutions and medical centres across 23 different ...

Scientists from Tomsk Polytechnic University, in collaboration with their colleagues, supported by the federal Priority-2030 ...

and nanotechnology approaches (such as nanoparticle-based theranostics) to the diagnosis and treatment of cancer. Nanocarriers can be used for accurate tumor targeting, but their limited water ...